RARE vs VCTR · rev $560.2M vs P/E 14, rev $893.5M
Ultragenyx (RARE) versus Victory Capital Holdings Inc (VCTR) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Victory Capital Holdings Inc (VCTR) is a asset management company listed on US.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported VCTR revenue for 2024-12-31 was $893.5M. Net income was $288.9M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
RARE currently screens at market cap $2.79B. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
Not investment advice. Open the RARE and VCTR stock pages for the full models.
Not investment advice.